The extremely low concentration of vitamin B,2 in normal and B.2-deficient blood has, heretofore, necessitated the use of microbiologic methods for its assay. Such bioassays are not only indirect and time consuming, but also require particular bacteriologic skills. In an earlier report from this laboratory (1) preliminary data were presented describing a simplified method for assaying this vitamin based on the competition between unlabeled vitamin B12 and isotopically labeled vitamin B12 for the binding sites of intrinsic factor. This investigation was prompted by the observation that the electrophoretic mobility of Co60B1, could be altered by prior incubation with intrinsic factor (IF). Similar findings had been made by Schilling and Deiss (2) using human gastric juice instead of IF. Figure 1 is a diagrammatic illustration of radioelectroplhoretograms of free and IF-bound Co6OB12. Whereas free Co60B12 has essentially no electrophoretic mobility ( Figure  1A ), when bound to IF, it migrates toward the anode ( Figure 1B) . If the IF is incubated with a mixture of Co60BJ, and unlabeled B12, less of the Co60B,, will be bound because of the competition now present for the binding sites of IF. Two peaks of radioactivity appear, the free unbound Co60B,, at the origin and that bound to the IF ( Figure 1C) .
The extremely low concentration of vitamin B,2 in normal and B.2-deficient blood has, heretofore, necessitated the use of microbiologic methods for its assay. Such bioassays are not only indirect and time consuming, but also require particular bacteriologic skills. In an earlier report from this laboratory (1) preliminary data were presented describing a simplified method for assaying this vitamin based on the competition between unlabeled vitamin B12 and isotopically labeled vitamin B12 for the binding sites of intrinsic factor. This investigation was prompted by the observation that the electrophoretic mobility of Co60B1, could be altered by prior incubation with intrinsic factor (IF). Similar findings had been made by Schilling and Deiss (2) using human gastric juice instead of IF. Figure 1 is a diagrammatic illustration of radioelectroplhoretograms of free and IF-bound Co6OB12. Whereas free Co60B12 has essentially no electrophoretic mobility ( Figure  1A ), when bound to IF, it migrates toward the anode ( Figure 1B) . If the IF is incubated with a mixture of Co60BJ, and unlabeled B12, less of the Co60B,, will be bound because of the competition now present for the binding sites of IF. Two peaks of radioactivity appear, the free unbound Co60B,, at the origin and that bound to the IF ( Figure 1C ) . These findings are similar to those reported by Berson and co-workers (3) on the binding of insulin-I131 by specific anti-insulin antibodies in studies employing paper electrophoresis. As they exploited their observations in developing an immunoassay for insulin (4, 5) , so it seemed possible that the inverse relationship between the ratio of bound to free Co60B,2 and total concen-* Supported by U. S. Public Health Service grant AM06045-02. Presented in part at the 9th Congress of the International Society of Hematology, Mexico City, September, 1962. tration of unlabeled B.2 might be similarly applied to the assay of cyanocobalamin.
These initial observations were made using mil- Separation of bound and free B,,. The IF-B,2 complex is precipitated by the addition of 0.5 ml of 5%o ZnSO4 followed by 1 ml of 0.175 N Ba(OH)2 added dropwise with frequent shaking. To insure the complete precipitation of such a small amount of IF protein, eight IAI of a 25% sterile solution of human serum albumin,2 2.0 mg, is added to each tube just before precipitation. Other sources of albumin were found to bind more than 5% of the Co"TBi, and should not be used. To keep the final solution containing the precipitate below pH 8, the exact ratio of Ba(OH),. to ZnSO4 should be checked with phenolphthalein as the indicator.
Standard curve. Storage of crystalline B,2 in the very low concentrations used for the standard appears to diminish its stability. Accordingly, serial dilutions of crystalline B,2 are made in the ACR buffer from a concentrated stock solution to give final concentrations of 10, 40, 80, 120, and 160 Rug per ml. A fixed amount of Co"B,2 (60 to 80 *sg) in 50-IAI quantities was then added to 1 ml of these standard solutions. The IF is then added (always last), and the mixture incubated at room temperature for 1 hour. It appeared that more consistent results were obtained if the incubation mixture was gently agitated. The precipitation is then carried out as described. Because of the low counting rate, it is desirable to count as much of the supernatant fluid as possible to determine the free Co'B,2. An efficient method is to separate the precipitate by passing the mixture through a 14-mm Buchner funnel with suction.3 At least 2 ml of the filtrate can then be counted (out of the final volume of 2.6 ml). Sufficient counts are recorded for a counting error of 1.2%o or less. The percentages of Co"B,2 bound (B) and free (F) are calculated, and a standard curve is obtained by plotting the B/F ratio as a function of the concentration of unlabeled crystalline B12. Replicate determinations vary less than 3% in the percentage bound.
Preparation of serum extracts. Because vitamin B,2 in the blood is bound to a specific carrier protein, it is necessary to extract the serum to be assayed. It is also of vital importance that the extract itself bind none of the Co17B12 to be added subsequently. Several different extraction methods were tested, but some sera failed to be completely deproteinated and substances remaining in the extract would interfere in the assay. The best method proved to be a double boiling procedure in the presence of cyanide, first at pH 4.6 and again at pH 5.6. To remove all traces of these binding substances, the extracts are filtered through a small Seitz filter pad with a syringe and Swinney adapter. Less than 5% of Co"7B,2
added to the extract is removed by the filter pad, thus indicating no significant loss of free B12 by this procedure.
This extraction results in a final fourfold dilution of the serum. Co5"B,2 and IF, in the same amounts used for Serum B12 levels were determined in 20 patients with megaloblastic anemia, 3 patients with chronic myelogenous leukemia, 4 patients with liver disease, and 35 normal control subjects (nurses, medical students, and blood donors). Figure 4 illustrates graphically the serum B12 level of each individual in each group. Table IV summarizes the range found in each group: 160 to 800 su&g per ml in normal subjects, 4 to 70 Auag per ml in B12-deficient patients, 1,000 to 1,970 uug per ml in the patients with chronic myelogenous leukemia, and 936 to 1,700 u/Ag per ml in the patients with liver disease.
Recovery of crystalline B12 added to B12-deficient and normal serum before extraction is illustrated in Figure 5 . The range of recovery was 85 to 102%, with a mean of 94% for the group. The better recovery from normal serum suggests that when the specific B12-binding protein is not mally saturated, other serum proteins bind th added B12 with greater tenacity than the specifi binder, and there is loss of the B12 during extra tion due to coprecipitation with these proteins.
To obtain a more precise comparison of met} ods, some sera were assayed by this radioassa procedure and microbiologically with Euglei gracilis and Lactobacillus lactis. These result are summarized in Table V . The Euglena assay were consistently and significantly higher, bot in normal subjects and patients with B12-deficiet megaloblastic anemia. On the other hand, Lack bacillus assays of serum from the B12-deficient sut jects were in closer agreement with the radiois tope assays.
DISCUSSION
If radioisotopically labeled molecules are to t used for assay purposes by the principle of con petitive inhibition, it is necessary that the rear tions between the labeled and unlabeled counte parts be identical. That IF will bind isotopical' labeled B12 and crystalline B12 in an identical way seems assured because the radioactivity is introduced via the cobalt atom, which is an integral part of the B12 molecule. This conclusion is also supported by experimental evidence (6) which demonstrates that Co6°B12 and unlabeled vitamin B12 will compete for the binding sites of normal human gastric juice.
Although the instability of IF with prolonged storage is somewhat of a problem, the rapidity of its interaction with vitamin B12 2) By this method, the serum vitamin B12 concentration in normal control subjects was 160 to 800 jutg per ml, and in patients with B,,-deficient megaloblastic anemia, 4 to 70 /A/ug per ml. Patients with chronic myelogenous leukemia and liver disease had levels much higher than normal.
3) Crystalline B12 added in vitro to serum before extraction was quantitatively recovered with an efficiency of 85 to 102%o. 4 
